Long Noncoding RNAs-LET Behave as a Noncoding Signature for Early-Onset Menarche and Late-Onset Menopause in Breast Cancer Patients
AbstractBackground: Breast cancer (BC) as a major cause of cancer-related death in women shows a very complex molecular and clinical phenotype, which has reduced the effectiveness of medical interventions. Evidence suggests that long noncoding RNAs (lncRNAs) are responsible for an important part of this complexity. This study aims to assess the expression and clinical implication of lncRNA LET in the pathobiology of BC. Materials and Methods: Quantitative real-time polymerase chain reaction was used to measure the expression of lncRNA-LET in breast tumors and adjacent normal-appearing tissues from 4 BC patients, as well as normal mammary tissues. Moreover, a bioinformatics approach was applied to uncover the potential lncRNA-LET-mediated sponge regulatory network as LET/miRNA/mRNA crosstalk. Results: Our study revealed that lncRNA-LET was significantly down-expressed not only in breast tumors but also in normal appearing breast tissues samples from BC subjects compared with true normal breast tissues obtained from healthy women. The low level of lncRNA-LET was meaningfully associated with early-onset menarche (≤13 years) and late-onset menopause (≥50) in patients. Moreover, the bioinformatics analyses support that lncRNA-LET could function as a tumor suppressor miRNA sponge. Conclusion: The results indicate that normal appearing breast tissues can undergo tumor-related molecular changes. Furthermore, they reveal the potential role of the dysregulation in LET-mediated ceRNA network in the pathophysiology of BC.
Bray, F., et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 2018. 68(6): p. 394-424.
Piao, H.-l. and L. Ma, Non-coding RNAs as regulators of mammary development and breast cancer. Journal of mammary gland biology and neoplasia, 2012. 17(1): p. 33-42.
Prensner, J.R. and A.M. Chinnaiyan, The emergence of lncRNAs in cancer biology. Cancer discovery, 2011. 1(5): p. 391-407.
Oliveira-Mateos, C., A. Sánchez-Castillo, and S. Guil, Noncoding RNAs as Regulators of Gene Expression in Pluripotency and Differentiation, in Epigenetics and Regeneration. 2019, Elsevier. p. 73-105.
Du, Z., et al., Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nature communications, 2016. 7: p. 10982.
Xiao, B., et al., Analysis of the miRNA–mRNA–lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data. Gene, 2018. 658: p. 28-35.
Jiang, S., H.-L. Wang, and J. Yang, Low expression of long non-coding RNA LET inhibits carcinogenesis of cervical cancer. International journal of clinical and experimental pathology, 2015. 8(1): p. 806.
Sun, Q., et al., Long noncoding RNA-LET, which is repressed by EZH2, inhibits cell proliferation and induces apoptosis of nasopharyngeal carcinoma cell. Medical oncology, 2015. 32(9): p. 226.
Liu, B., et al., Long noncoding RNA-LET suppresses tumor growth and EMT in lung adenocarcinoma. BioMed research international, 2016. 2016.
Yang, F., et al., Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Molecular cell, 2013. 49(6): p. 1083-1096.
Försti, A., et al., Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. European journal of cancer, 2001. 37(11): p. 1372-1380.
Clare, S., et al., Abstract P1-03-02:“Normal” tissue adjacent to breast cancer is not normal. 2012, AACR.
Ma, M.z., et al., Long non‐coding RNA‐LET is a positive prognostic factor and exhibits tumor‐suppressive activity in gallbladder cancer. Molecular carcinogenesis, 2015. 54(11): p. 1397-1406.
Chandran, U.R., et al., Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC cancer, 2005. 5(1): p. 45.
Deng, G., et al., Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science, 1996. 274(5295): p. 2057-2059.
Widschwendter, M., et al., Loss of retinoic acid receptor β expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer research, 1997. 57(19): p. 4158-4161.
Takalkar, U., et al., Hormone related risk factors and breast cancer: Hospital based case control study from India. Breast cancer, 2020(2).
Dall, G.V. and K.L. Britt, Estrogen effects on the mammary gland in early and late life and breast cancer risk. Frontiers in oncology, 2017. 7: p. 110.
Niknafs, Y.S., et al., The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression. Nature communications, 2016. 7: p. 12791.
Taylor, D.H., et al., Long non‐coding RNA regulation of reproduction and development. Molecular reproduction and development, 2015. 82(12): p. 932-956.
Mansoori, Y., et al., Expression levels of breast cancer‐related GAS 5 and LSINCT 5 lnc RNA s in cancer‐free breast tissue: Molecular associations with age at menarche and obesity. The breast journal, 2018. 24(6): p. 876-882.
Jonsson, P., et al., Single-molecule sequencing reveals estrogen-regulated clinically relevant lncRNAs in breast cancer. Molecular Endocrinology, 2015. 29(11): p. 1634-1645.
Wang, X.-l., et al., Testis specific serine/threonine protein kinase 4 (TSSK4) leads to cell apoptosis relying on its kinase activity. Journal of Huazhong University of Science and Technology [Medical Sciences], 2015. 35(2): p. 235-240.
Greaves, J. and L.H. Chamberlain, New links between S‐acylation and cancer. The Journal of pathology, 2014. 233(1): p. 4-6.
Yeste‐Velasco, M., et al., Identification of ZDHHC14 as a novel human tumour suppressor gene. The Journal of pathology, 2014. 232(5): p. 566-577.
Shyr, C.-R., et al., Modulation of estrogen receptor-mediated transactivation by orphan receptor TR4 in MCF-7 cells. Journal of Biological Chemistry, 2002. 277(17): p. 14622-14628.
Kim, M.S., et al., Somatic mutations and losses of expression of microRNA regulation‐related genes AGO2 and TNRC6A in gastric and colorectal cancers. The Journal of pathology, 2010. 221(2): p. 139-146.
Je, E.M., S.H. Lee, and N.J. Yoo, Loss of RNA‐induced silencing complex‐related proteins in non‐small cell lung cancers. Apmis, 2013. 121(5): p. 460-462.
Kang, L., et al., miR-26a-5p regulates TNRC6A expression and facilitates theca cell proliferation in chicken ovarian follicles. DNA and cell biology, 2017. 36(11): p. 922-929.
Muhanhali, D., et al., Long non-coding antisense RNA TNRC6C-AS1 is activated in papillary thyroid cancer and promotes cancer progression by suppressing TNRC6C expression. Frontiers in endocrinology, 2018. 9: p. 360.
Ivanovska, I., et al., MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Molecular and cellular biology, 2008. 28(7): p. 2167-2174.
Li, N., et al., MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer. Cell death & disease, 2017. 8(5): p. e2796.
Yu, Z., et al., A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. The Journal of cell biology, 2008. 182(3): p. 509-517.
Hayashita, Y., et al., A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer research, 2005. 65(21): p. 9628-9632.
Hossain, A., M.T. Kuo, and G.F. Saunders, Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Molecular and cellular biology, 2006. 26(21): p. 8191-8201.
Matsubara, H., et al., Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene, 2007. 26(41): p. 6099.
Xu, X., et al., miR‐374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer. FEBS letters, 2015. 589(3): p. 407-413.
Copyright (c) 2021 Galen Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).